Morgan Stanley Series F Preferred Stock
MS.PRF
2 hedge funds and large institutions have $2.52M invested in Morgan Stanley Series F Preferred Stock in 2023 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, reducing their positions, and 1 closing their positions.
16,233% more capital invested
Capital invested by funds: $15.4K → $2.52M (+$2.5M)
0.29% more ownership
Funds ownership: 0% → 0.3% (+0.29%)
0% more funds holding
Funds holding: 2 → 2 (0)
0% more first-time investments, than exits
New positions opened: 1 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
IR
IAT Reinsurance
New York
|
+$2.5M |
| 2 |
PNC Financial Services Group
Pittsburgh,
Pennsylvania
|
+$2.38K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OP
ORG Partners
Roanoke,
Indiana
|
-$500 |
MS.PRF Hedge Fund Activity: Q4 2023 in Review
2 of the 6,860 institutional investors tracked by Wall St. Rank reported a position in Morgan Stanley Series F Preferred Stock (MS.PRF) for Q4 2023, worth a combined $2.52M — up 16,233% from $15.4K a quarter earlier.
Fund positioning in MS.PRF was balanced in Q4 2023: 1 fund opened new positions, 1 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was IAT Reinsurance, opening a new position worth an estimated $2.5M. The largest seller was ORG Partners, exiting entirely with an estimated $500 sold.
- 2 institutional investors held Morgan Stanley Series F Preferred Stock (MS.PRF) as of Q4 2023, unchanged from Q3 2023.
- Funds reported $2.52M of Morgan Stanley Series F Preferred Stock stock for Q4 2023, up 16,233% quarter-over-quarter.
- 1 fund opened new Morgan Stanley Series F Preferred Stock positions in Q4 2023 and 1 closed out, a net change of 0 holders.
- The largest Morgan Stanley Series F Preferred Stock buyer in Q4 2023 was IAT Reinsurance, an estimated $2.5M added.
- The largest Morgan Stanley Series F Preferred Stock seller in Q4 2023 was ORG Partners, an estimated $500 sold.
Based on aggregated 13F filings for Q4 2023.